Serum biomarker release patterns following alcohol septal ablation for treatment of hypertrophic cardiomyopathy

Alcohol septal ablation (ASA) is employed to relieve the pressure gradient associated with symptomatic hypertrophic cardiomyopathy. Serum concentrations of cardiac troponin I, creatine kinase MB band, brain natriuretic protein, matrix metalloproteinase-9, myoglobin, C-reactive protein, tumor necrosi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Current biomarker findings 2014-01, Vol.4, p.161
Hauptverfasser:	Foley, Joseph D, Miller, Craig S, Sneed, J. Darrell, Ebersole, Jeffrey L, Kryscio, Richard J, McDevitt, John T, Campbell, Charles L
Format:	Artikel
Sprache:	eng
Schlagworte:	Ablation Alcohol Analysis Biomarkers C-reactive protein Cardiomyopathy Cardiovascular disease Care and treatment Catheters Coronary vessels Diagnosis Dyspnea Electrocardiography Family medical history Genetic aspects Heart attacks Heart failure Hypertrophic cardiomyopathy Kinetics Myoglobin Peptides Physiological aspects Troponin Veins & arteries
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!